312 related articles for article (PubMed ID: 18574012)
1. Lutein and zeaxanthin for macular degeneration.
Zhao L; Sweet BV
Am J Health Syst Pharm; 2008 Jul; 65(13):1232-8. PubMed ID: 18574012
[TBL] [Abstract][Full Text] [Related]
2. Effect of lutein and zeaxanthin on macular pigment and visual function in patients with early age-related macular degeneration.
Ma L; Yan SF; Huang YM; Lu XR; Qian F; Pang HL; Xu XR; Zou ZY; Dong PC; Xiao X; Wang X; Sun TT; Dou HL; Lin XM
Ophthalmology; 2012 Nov; 119(11):2290-7. PubMed ID: 22858124
[TBL] [Abstract][Full Text] [Related]
3. Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
Ma L; Dou HL; Wu YQ; Huang YM; Huang YB; Xu XR; Zou ZY; Lin XM
Br J Nutr; 2012 Feb; 107(3):350-9. PubMed ID: 21899805
[TBL] [Abstract][Full Text] [Related]
4. Resonance Raman measurement of macular carotenoids in normal subjects and in age-related macular degeneration patients.
Bernstein PS; Zhao DY; Wintch SW; Ermakov IV; McClane RW; Gellermann W
Ophthalmology; 2002 Oct; 109(10):1780-7. PubMed ID: 12359594
[TBL] [Abstract][Full Text] [Related]
5. Effect of Dietary Supplementation With Lutein, Zeaxanthin, and ω-3 on Macular Pigment: A Randomized Clinical Trial.
Korobelnik JF; Rougier MB; Delyfer MN; Bron A; Merle BMJ; Savel H; Chêne G; Delcourt C; Creuzot-Garcher C
JAMA Ophthalmol; 2017 Nov; 135(11):1259-1266. PubMed ID: 28973076
[TBL] [Abstract][Full Text] [Related]
6. Improvement of retinal function in early age-related macular degeneration after lutein and zeaxanthin supplementation: a randomized, double-masked, placebo-controlled trial.
Ma L; Dou HL; Huang YM; Lu XR; Xu XR; Qian F; Zou ZY; Pang HL; Dong PC; Xiao X; Wang X; Sun TT; Lin XM
Am J Ophthalmol; 2012 Oct; 154(4):625-634.e1. PubMed ID: 22835510
[TBL] [Abstract][Full Text] [Related]
7. Secondary analyses of the effects of lutein/zeaxanthin on age-related macular degeneration progression: AREDS2 report No. 3.
; Chew EY; Clemons TE; Sangiovanni JP; Danis RP; Ferris FL; Elman MJ; Antoszyk AN; Ruby AJ; Orth D; Bressler SB; Fish GE; Hubbard GB; Klein ML; Chandra SR; Blodi BA; Domalpally A; Friberg T; Wong WT; Rosenfeld PJ; Agrón E; Toth CA; Bernstein PS; Sperduto RD
JAMA Ophthalmol; 2014 Feb; 132(2):142-9. PubMed ID: 24310343
[TBL] [Abstract][Full Text] [Related]
8. Dietary lutein, zeaxanthin, and fats and the progression of age-related macular degeneration.
Robman L; Vu H; Hodge A; Tikellis G; Dimitrov P; McCarty C; Guymer R
Can J Ophthalmol; 2007 Oct; 42(5):720-6. PubMed ID: 17724493
[TBL] [Abstract][Full Text] [Related]
9. Effect of dietary lutein and zeaxanthin on plasma carotenoids and their transport in lipoproteins in age-related macular degeneration.
Wang W; Connor SL; Johnson EJ; Klein ML; Hughes S; Connor WE
Am J Clin Nutr; 2007 Mar; 85(3):762-9. PubMed ID: 17344498
[TBL] [Abstract][Full Text] [Related]
10. Associations between intermediate age-related macular degeneration and lutein and zeaxanthin in the Carotenoids in Age-related Eye Disease Study (CAREDS): ancillary study of the Women's Health Initiative.
Moeller SM; Parekh N; Tinker L; Ritenbaugh C; Blodi B; Wallace RB; Mares JA;
Arch Ophthalmol; 2006 Aug; 124(8):1151-62. PubMed ID: 16908818
[TBL] [Abstract][Full Text] [Related]
11. Macular xanthophylls and ω-3 long-chain polyunsaturated fatty acids in age-related macular degeneration: a randomized trial.
Arnold C; Winter L; Fröhlich K; Jentsch S; Dawczynski J; Jahreis G; Böhm V
JAMA Ophthalmol; 2013 May; 131(5):564-72. PubMed ID: 23519529
[TBL] [Abstract][Full Text] [Related]
12. Lutein, Zeaxanthin and Meso-zeaxanthin Supplementation Associated with Macular Pigment Optical Density.
Ma L; Liu R; Du JH; Liu T; Wu SS; Liu XH
Nutrients; 2016 Jul; 8(7):. PubMed ID: 27420092
[TBL] [Abstract][Full Text] [Related]
13. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans.
Bone RA; Landrum JT; Guerra LH; Ruiz CA
J Nutr; 2003 Apr; 133(4):992-8. PubMed ID: 12672909
[TBL] [Abstract][Full Text] [Related]
14. [Macular pigment and age-related macular degeneration. Clinical implications].
Haddad WM; Souied E; Coscas G; Soubrane G
Bull Soc Belge Ophtalmol; 2006; (301):15-22. PubMed ID: 17552428
[TBL] [Abstract][Full Text] [Related]
15. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.
Age-Related Eye Disease Study 2 Research Group
JAMA; 2013 May; 309(19):2005-15. PubMed ID: 23644932
[TBL] [Abstract][Full Text] [Related]
16. Oral supplementation of lutein/zeaxanthin and omega-3 long chain polyunsaturated fatty acids in persons aged 60 years or older, with or without AMD.
Huang LL; Coleman HR; Kim J; de Monasterio F; Wong WT; Schleicher RL; Ferris FL; Chew EY
Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):3864-9. PubMed ID: 18450596
[TBL] [Abstract][Full Text] [Related]
17. Associations between lutein, zeaxanthin, and age-related macular degeneration: an overview.
Carpentier S; Knaus M; Suh M
Crit Rev Food Sci Nutr; 2009 Apr; 49(4):313-26. PubMed ID: 19234943
[TBL] [Abstract][Full Text] [Related]
18. [The macular pigment: short- and intermediate-term changes of macular pigment optical density following supplementation with lutein and zeaxanthin and co-antioxidants. The LUNA Study].
Zeimer M; Hense HW; Heimes B; Austermann U; Fobker M; Pauleikhoff D
Ophthalmologe; 2009 Jan; 106(1):29-36. PubMed ID: 18551295
[TBL] [Abstract][Full Text] [Related]
19. Lutein and zeaxanthin supplementation and association with visual function in age-related macular degeneration.
Liu R; Wang T; Zhang B; Qin L; Wu C; Li Q; Ma L
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):252-8. PubMed ID: 25515572
[TBL] [Abstract][Full Text] [Related]
20. Intakes of Lutein, Zeaxanthin, and Other Carotenoids and Age-Related Macular Degeneration During 2 Decades of Prospective Follow-up.
Wu J; Cho E; Willett WC; Sastry SM; Schaumberg DA
JAMA Ophthalmol; 2015 Dec; 133(12):1415-24. PubMed ID: 26447482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
